Christou M, Savas U, Spink D C, Gierthy J F, Jefcoate C R
Department of Pharmacology, University of Wisconsin Medical School, Madison 53706.
Carcinogenesis. 1994 Apr;15(4):725-32. doi: 10.1093/carcin/15.4.725.
Cultured human mammary carcinoma (MCF-7) cells exhibited constitutive cytochrome P450-dependent metabolism of 7,12-dimethylbenz[a]anthracene (DMBA) (45-75 pmol/mg microsomal protein). Exposure of the cells to 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD), which is known to induce CYP1A1, not only resulted in a 30-fold increase in the total microsomal metabolism of DMBA but produced substantial differences in the distribution of DMBA metabolites formed. This suggested that different cytochrome P450 (P450) forms predominated in untreated and induced cells. Comparative studies with TCDD-induced human hepatoblastoma (HepG2) and skin cell carcinoma (SCC-13) cells and also recombinantly expressed human CYP1A1, confirmed that the DMBA-metabolite profile in TCDD-induced MCF-7 cells was that of human CYP1A1. This distribution, however, differed substantially from the regioselectivity of rat CYP1A1 and mouse Cyp1a-1. Rabbit antibodies to rat CYP1A1 completely inhibited the DMBA-metabolizing activity of TCDD-induced MCF-7 cells but had no inhibitory effect on constitutive DMBA metabolism which was, however, completely inhibited by chicken antibodies to the novel P450 in mouse embryo fibroblasts (P450-EF). Anti-P450-EF inhibited only 10% of the DMBA-metabolizing activity in the TCDD-induced MCF-7 cell microsomes. Microsomes from untreated MCF-7 cells expressed a 52 kDa protein that was immunodetectable by rabbit anti-P450-EF and failed to express immunodetectable levels of human CYP1A1. DMBA metabolism, therefore, switches from P450-EF in uninduced microsomes to CYP1A1 in TCDD-induced microsomes. The mobility of the P450-EF-like protein in MCF-7 cells was higher than that of P450-EF from C3H/10T1/2CL8 (10T1/2) cells (55 kDa). The 52 kDa protein from MCF-7 cells was induced approximately 8-fold by TCDD while CYP1A1 immunodetectable protein was increased to much higher levels. The SCC-13 cell line exhibited a similar pattern of expression of a 52 kDa P450-EF-like protein and CYP1A1. HepG2 cells expressed the highest levels of CYP1A1 in response to TCDD without expression of the 52 kDa protein.
培养的人乳腺癌(MCF-7)细胞表现出对7,12-二甲基苯并[a]蒽(DMBA)的组成型细胞色素P450依赖性代谢(45 - 75 pmol/mg微粒体蛋白)。将细胞暴露于已知可诱导CYP1A1的2,3,7,8-四氯二苯并-对-二恶英(TCDD),不仅导致DMBA的总微粒体代谢增加30倍,而且在形成的DMBA代谢物分布上产生了显著差异。这表明在未处理和诱导的细胞中,不同的细胞色素P450(P450)形式占主导地位。对TCDD诱导的人肝癌细胞(HepG2)和皮肤癌细胞(SCC-13)以及重组表达的人CYP1A1进行的比较研究证实,TCDD诱导的MCF-7细胞中的DMBA代谢物谱是人类CYP1A1的谱。然而,这种分布与大鼠CYP1A1和小鼠Cyp1a-1的区域选择性有很大不同。针对大鼠CYP1A1的兔抗体完全抑制了TCDD诱导的MCF-7细胞的DMBA代谢活性,但对组成型DMBA代谢没有抑制作用,而小鼠胚胎成纤维细胞(P450-EF)中针对新型P450的鸡抗体则完全抑制了组成型DMBA代谢。抗P450-EF仅抑制了TCDD诱导的MCF-7细胞微粒体中10%的DMBA代谢活性。未处理的MCF-7细胞的微粒体表达一种52 kDa的蛋白,兔抗P450-EF可免疫检测到该蛋白,且未表达可免疫检测水平的人类CYP1A1。因此,DMBA代谢从未诱导微粒体中的P450-EF转变为TCDD诱导微粒体中的CYP1A1。MCF-7细胞中P450-EF样蛋白的迁移率高于C3H/10T1/2CL8(10T1/2)细胞中P450-EF的迁移率(55 kDa)。MCF-7细胞中的52 kDa蛋白被TCDD诱导增加了约8倍,而可免疫检测到的CYP1A1蛋白增加到更高水平。SCC-13细胞系表现出类似的52 kDa P450-EF样蛋白和CYP1A1表达模式。HepG2细胞在对TCDD的反应中表达最高水平的CYP1A1,而未表达52 kDa蛋白。